Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Journals Online Team and American Society of Clinical Oncology (ASCO). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Journals Online Team and American Society of Clinical Oncology (ASCO) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

JCO Article Insights: Simultaneous Durvalumab and CRT in Unresectable Stage III NSCLC

10:31
 
Share
 

Manage episode 521027503 series 9910
Content provided by Journals Online Team and American Society of Clinical Oncology (ASCO). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Journals Online Team and American Society of Clinical Oncology (ASCO) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, "Simultaneous Durvalumab and Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer" by Bradley, et al published October 13, 2025.

TRANSCRIPT TO COME

DISCLOSURES

Dr. Bradley Honoria: Mevion Medical Systems, Inc. Consulting or Advisory Role: Varian, Inc, Genentech, Inc. Research Funding: Varian Medical Systems

Dr. Cali Research Funding Company: BeiGene, Nuvalent, Inc., Astra Zeneca

  continue reading

444 episodes

Artwork
iconShare
 
Manage episode 521027503 series 9910
Content provided by Journals Online Team and American Society of Clinical Oncology (ASCO). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Journals Online Team and American Society of Clinical Oncology (ASCO) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode of JCO Article Insights, host Dr. Ece Cali Daylan interviews author Dr. Jeffrey Bradley about the article, "Simultaneous Durvalumab and Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer" by Bradley, et al published October 13, 2025.

TRANSCRIPT TO COME

DISCLOSURES

Dr. Bradley Honoria: Mevion Medical Systems, Inc. Consulting or Advisory Role: Varian, Inc, Genentech, Inc. Research Funding: Varian Medical Systems

Dr. Cali Research Funding Company: BeiGene, Nuvalent, Inc., Astra Zeneca

  continue reading

444 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play